|
2020 Journal Article Is there a causal link between psychological disorders and functional gastrointestinal disorders?Koloski, Natasha, Holtmann, Gerald and Talley, Nicholas J. (2020). Is there a causal link between psychological disorders and functional gastrointestinal disorders?. Expert Review of Gastroenterology and Hepatology, 14 (11), 1-13. doi: 10.1080/17474124.2020.1801414 |
|
2019 Conference Publication Functional Gastrointestinal Disorders (FGIDs) patients benefit from a 12-weeks multidisciplinary integrated treatment approach to reduce gastrointestinal symptoms, anxiety and depressive symptomsBray, Nicola, Koloski, Natasha, Jones, Michael, Do, Anh, Talley, Nicholas, Billin, Abbi, Bettens, Gemma, Mcallister, Sarah, Pang, Siong, Arthur, Leela, Campos, Jane, Chao, Jeff and Holtmann, Gerald (2019). Functional Gastrointestinal Disorders (FGIDs) patients benefit from a 12-weeks multidisciplinary integrated treatment approach to reduce gastrointestinal symptoms, anxiety and depressive symptoms. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW), Adelaide, SA, Australia, 8–10 September 2019. Hoboken, NJ, United States: Wiley-Blackwell. |
|
2019 Conference Publication Diagnostic yield and healthcare resource utilization of Eesophagogastroduodenoscopy in patients referred for colonoscopy for investigation of positive Fecal Occult Blood Test (FOBT plus )Shah, Ayesha, Kutyla, Marguerite, Hansen, Teressa, Virgo, Kate, Koloski, Natasha, Huelsen-Katz, Alexander, Martin, Neal, Maqboul, Nadia, Chao, Che-Yung, Whaley, Amanda, Hourigan, Luke and Holtmann, Gerald (2019). Diagnostic yield and healthcare resource utilization of Eesophagogastroduodenoscopy in patients referred for colonoscopy for investigation of positive Fecal Occult Blood Test (FOBT plus ). Asia Pacific Digestive Week (APDW), Kolkata, India, 12–15 December 2019. Richmond, VIC Australia: John Wiley & Sons. |
|
2019 Journal Article Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac diseaseDaveson, A. James M., Tye-Din, Jason A., Goel, Gautam, Goldstein, Kaela E., Hand, Holly L., Neff, Kristin M., Williams, Leslie J., Truitt, Kenneth E., Anderson, Robert P., on behalf of the RESET CeD Study Group, Adams, A., Andrews, J., Behrend, C., Brown, G., Mei, S. Chen Yi, Coates, A., Daveson, A. J. M., DiMarino, A., Ee, H., Elliott, D., Epstein, R., Feyen, B., Fogel, R., Friedenberg, K., Gearry, R., Gerdis, M., Goldstein, M., Gupta, V., Holmes, R. ... Wilson, S. (2019). Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease. Alimentary Pharmacology & Therapeutics, 51 (2), 244-252. doi: 10.1111/apt.15551 |
|
2019 Conference Publication A 12-week multidisciplinary integrated treatment approach is superior to standard care for symptom reduction in patients with functional gastrointestinal disorders: A case-control studyBray, N., Koloski, N., Jones, M., Do, A., Talley, N., Billin, A., Bettens, G., McAllister, S., Pang, S., Arthur, L., Campos, J., Chao, C., Catague, R., Whalley, A., MacDonald, G. and Holtmann, G. (2019). A 12-week multidisciplinary integrated treatment approach is superior to standard care for symptom reduction in patients with functional gastrointestinal disorders: A case-control study. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW), Adelaide, SA, Australia, 8–10 September 2019. Hoboken, NJ, United States: Wiley-Blackwell. |
|
2019 Conference Publication A hospital-based, multidisciplinary approach to lifestyle management is effective in patients with non-alcoholic fatty liver diseaseBritton, L., Stewart, A., Campos, J., Robertson, T., Mcallister, S., De Maria, K., Catague, R., Wright, P., Holtmann, G. and MacDonald, G. (2019). A hospital-based, multidisciplinary approach to lifestyle management is effective in patients with non-alcoholic fatty liver disease. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) “The Universe Within”, Adelaide, SA, Australia, 8–10 September 2019. Richmond, VIC, Australia: Wiley-Blackwell. |
|
2019 Conference Publication Patients with functional gastrointestinal disorders benefit from a 12-week multidisciplinary integrated treatment approach to reduce anxiety and depressive symptomsBray, N., Koloski, N., Jones, M., Do, A., Talley, N., Billin, A., Bettens, G., Mcallister, S., Pang, S., Arthur, L., Campus, J., Chao, C., Catague, R., Whaley, A., Macdonald, G. and Holtmann, G. (2019). Patients with functional gastrointestinal disorders benefit from a 12-week multidisciplinary integrated treatment approach to reduce anxiety and depressive symptoms. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW), Adelaide, SA, Australia, 8–10 September 2019. Hoboken, NJ, United States: Wiley-Blackwell. |
|
2019 Conference Publication Duodenal Jejunal Bypass Liner (DJBL) for treatment of type 2 diabetes and obesity: the risk benefit ratio from the worldwide EndoBarrier (EB) registry in 871 patientsLaubner, K., Seufert, J., Aberle, J., Frydenberg, H., Munro, L., Fishman, S., Cohen, R., Holtmann, G., de Jonge, C., Greve, J., Kow, L., Bessell, J., Sourij, H., Benes, M. and Ryder, R. E. J. (2019). Duodenal Jejunal Bypass Liner (DJBL) for treatment of type 2 diabetes and obesity: the risk benefit ratio from the worldwide EndoBarrier (EB) registry in 871 patients. 55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), Barcelona Spain, Sep 16-20, 2019. NEW YORK: SPRINGER. |
|
2019 Journal Article The use of modelling studies to inform planning of health services: case study of rapidly increasing endoscopy services in AustraliaCarter, Hannah E., Knowles, Dylan, Moroney, Timothy, Holtmann, Gerald, Rahma, Tony, Appleyard, Mark, Steele, Nick, Zanco, Michael and Graves, Nicholas (2019). The use of modelling studies to inform planning of health services: case study of rapidly increasing endoscopy services in Australia. BMC Health Services Research, 19 (1) 608, 608. doi: 10.1186/s12913-019-4438-x |
|
2019 Journal Article Dysbiosis of the Duodenal Mucosal Microbiota Is Associated With Increased Small Intestinal Permeability in Chronic Liver DiseaseRaj, Ashok S., Shanahan, Erin R., Tran, Cuong D., Bhat, Purnima, Fletcher, Linda M., Vesey, David A., Morrison, Mark, Holtmann, Gerald and Macdonald, Graeme A. (2019). Dysbiosis of the Duodenal Mucosal Microbiota Is Associated With Increased Small Intestinal Permeability in Chronic Liver Disease. Clinical and Translational Gastroenterology, 10 (8) e00068, e00068. doi: 10.14309/ctg.0000000000000068 |
|
2019 Journal Article Circulating Anti-cytolethal Distending Toxin B and Anti-vinculin Antibodies as Biomarkers in Community and Healthcare Populations With Functional Dyspepsia and Irritable Bowel SyndromeTalley, Nicholas J., Holtmann, Gerald, Walker, Marjorie M., Burns, Grace, Potter, Michael, Shah, Ayesha, Jones, Michael, Koloski, Natasha A. and Keely, Simon (2019). Circulating Anti-cytolethal Distending Toxin B and Anti-vinculin Antibodies as Biomarkers in Community and Healthcare Populations With Functional Dyspepsia and Irritable Bowel Syndrome. Clinical and Translational Gastroenterology, 10 (7) e-00064, e00064. doi: 10.14309/ctg.0000000000000064 |
|
2019 Conference Publication In-vitro evaluation of antifoaming effects of simethicone: a dose-finding studyKutyla, Marguerite, Shah, Ayesha, Meeusen, Vera, Elson, Jerome, Heulsen-Katz, Alex, Hourigan, Luke F. and Holtmann, Gerald J. (2019). In-vitro evaluation of antifoaming effects of simethicone: a dose-finding study. Digestive Disease Week (DDW), San Diego, CA United States, 18-21 May 2019. Philadelphia, PA, United States: Elsevier. doi: 10.1016/j.gie.2019.03.070 |
|
2019 Journal Article An in vitro and clinical dose-finding study of antifoaming effects of simethicone during colonoscopyKutyla, Marguerite J., Shah, Ayesha, Elson, Jerome, Meeusen, Vera, O’Connor, Sam, Hourigan, Luke F. and Holtmann, Gerald J. (2019). An in vitro and clinical dose-finding study of antifoaming effects of simethicone during colonoscopy. Indian Journal of Gastroenterology, 38 (3), 268-272. doi: 10.1007/s12664-019-00966-3 |
|
2019 Conference Publication ENTERIC METHANE OR HYDROGEN PRODUCTION IN PATIENTS WITH UNEXPLAINED GASTROINTESTINAL SYMPTOMS: ASSOCIATIONS WITH AGE, SYMPTOMS AND PROTON PUMP INHIBITORSShah, Ayesha, Rich, Justin, Koloski, Natasha A., Morrison, Mark and Holtmann, Gerald J. (2019). ENTERIC METHANE OR HYDROGEN PRODUCTION IN PATIENTS WITH UNEXPLAINED GASTROINTESTINAL SYMPTOMS: ASSOCIATIONS WITH AGE, SYMPTOMS AND PROTON PUMP INHIBITORS. Digestive Disease Week (DDW), San Diego Ca, May 18-21, 2019. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC. |
|
2019 Conference Publication GLUTEN AVOIDANCE AND SELF-REPORTED NON-CELIAC WHEAT SENSITIVITY: INCIDENCE AND PREVALENCE FROM A LONGITUDINAL COHORT STUDY OF 1322 INDIVIDUALSPotter, Michael D., Jones, Michael P., Walker, Marjorie M., Keely, Simon, Koloski, Natasha A., Holtmann, Gerald J. and Talley, Nicholas J. (2019). GLUTEN AVOIDANCE AND SELF-REPORTED NON-CELIAC WHEAT SENSITIVITY: INCIDENCE AND PREVALENCE FROM A LONGITUDINAL COHORT STUDY OF 1322 INDIVIDUALS. Digestive Disease Week (DDW), San Diego Ca, May 18-21, 2019. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC. |
|
2019 Conference Publication INCIDENCE, PREVALENCE AND RISK FACTORS ASSOCIATED WITH FUNCTIONAL GASTROINTESTINAL DISORDERS: A LONGITUDINAL COHORT STUDY OF 1322 INDIVIDUALSPotter, Michael D., Jones, Michael P., Koloski, Natasha A., Walker, Marjorie M., Keely, Simon, Holtmann, Gerald J. and Talley, Nicholas J. (2019). INCIDENCE, PREVALENCE AND RISK FACTORS ASSOCIATED WITH FUNCTIONAL GASTROINTESTINAL DISORDERS: A LONGITUDINAL COHORT STUDY OF 1322 INDIVIDUALS. Digestive Disease Week (DDW), San Diego Ca, May 18-21, 2019. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC. |
|
2019 Conference Publication Weight loss and metabolic improvements one year after treatment with a duodenal-jejunal bypass sleeve (Endobarrier (R))McMaster, Jessica J., Shanahan, Erin R., Anh Do,, Rich, Graeme, Veronique, Chachay, Macdonald, Graeme A. and Holtmann, Gerald J. (2019). Weight loss and metabolic improvements one year after treatment with a duodenal-jejunal bypass sleeve (Endobarrier (R)). Digestive Disease Week (DDW), San Diego, CA USA, 18-21 May 2019. Philadelphia, PA USA: Elsevier. |
|
2019 Conference Publication A COMPARISON OF PATIENTS WITH UNEXPLAINED (FUNCTIONAL) SYMPTOMS OR ORGANIC GASTROINTESTINAL (GI) DISEASE: SYMPTOM SEVERITY, PSYCHIATRIC COMORBIDITIES, GASTROINTESTINAL DYSBIOSIS AND IMMUNE ACTIVIATIONShah, Ayesha, Do, Anh, Keely, Simon, Walker, Marjorie M., Hansen, Teressa J., Rich, Justin, Jones, Michael P., Koloski, Natasha A., Talley, Nicholas J., Morrison, Mark and Holtmann, Gerald J. (2019). A COMPARISON OF PATIENTS WITH UNEXPLAINED (FUNCTIONAL) SYMPTOMS OR ORGANIC GASTROINTESTINAL (GI) DISEASE: SYMPTOM SEVERITY, PSYCHIATRIC COMORBIDITIES, GASTROINTESTINAL DYSBIOSIS AND IMMUNE ACTIVIATION. Digestive Disease Week (DDW), San Diego Ca, May 18-21, 2019. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC. |
|
2019 Conference Publication THE IMMEDIATE AND DELAYED EFFECTS OF DISTURBED SLEEP ON PAIN AND NON- PAIN GASTROINTESTINAL SYMPTOMS: RESULTS FROM AN ECOLOGICAL MOMENTARY ASSESSMENT STUDYLee, Charis, Koloski, Natasha A., Jones, Michael P., Beath, Alissa P., Talley, Nicholas J. and Holtmann, Gerald J. (2019). THE IMMEDIATE AND DELAYED EFFECTS OF DISTURBED SLEEP ON PAIN AND NON- PAIN GASTROINTESTINAL SYMPTOMS: RESULTS FROM AN ECOLOGICAL MOMENTARY ASSESSMENT STUDY. Digestive Disease Week (DDW), San Diego Ca, May 18-21, 2019. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC. |
|
2019 Journal Article Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel diseaseShah, Ayesha, Morrison, Mark, Burger, Daniel, Martin, Neal, Rich, Justin, Jones, Mike, Koloski, Natasha, Walker, Marjorie M., Talley, Nicholas J. and Holtmann, Gerald J. (2019). Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease. Alimentary Pharmacology and Therapeutics, 49 (6), 624-635. doi: 10.1111/apt.15133 |
